Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10662/20145
Títulos: Meta-analysis of the effect of CYP2B6, CYP2A6, UGT2B7 and CAR polymorphisms on efavirenz plasma concentrations
Autores/as: Ayuso Parejo, Pedro
Neary, Megan
Chiong, Justin
Owen, Andrew
Palabras clave: Efavirenz;VIH;Polimorfismos;Polymorphisms;HIV;Plasma drug concentration;Concentración plasmática del fármaco;Homozygote;Homocigoto;CYP2B6 gene;CYP2A6 gene;UGT2B7 gene;Gen CYP2B6;Gen CYP2A6;Gen UGT2B7
Fecha de publicación: 2019
Editor/a: Oxford University Press
Resumen: Background: Efavirenz primary metabolism is catalysed by CYP2B6 with minor involvement of CYP2A6. Subsequently, phase I metabolites are conjugated by UGT2B7, and constitutive androstane receptor (CAR) has been shown to transcriptionally regulate many relevant enzymes and transporters. Several polymorphisms occurring in the genes coding for these proteins have been shown to impact efavirenz pharmacokinetics in some but not all studies. Objectives: A meta-analysis was performed to assess the overall effect of CYP2B6 rs3745274, CYP2A6 (rs28399454, rs8192726 and rs28399433), UGT2B7 (rs28365062 and rs7439366) and NR1I3 (rs2307424 and rs3003596) polymorphisms on mid-dose efavirenz plasma concentrations. Methods: Following a literature review, pharmacokinetic parameters were compiled and a meta-analysis for these variants was performed using Review Manager and OpenMetaAnalyst. A total of 28 studies were included. Results: Unsurprisingly, the analysis confirmed that individuals homozygous for the T allele for CYP2B6 rs3745274 had significantly higher efavirenz concentrations than those homozygous for the G allele [weighted standard mean difference (WSMD)=2.98; 95% CI 2.19–3.76; P<0.00001]. A subgroup analysis confirmed ethnic differences in frequency but with a similar effect size in each ethnic group (P=0.96). Associations with CYP2A6 and UGT2B7 variants were not statistically significant, but T homozygosity for CAR rs2307424 was associated with significantly lower efavirenz concentrations than in C homozygotes (WSMD=#0.32; 95% CI #0.59 to #0.06; P=0.02). Conclusions: This meta-analysis provides the overall effect size for the impact of CYP2B6 rs3745274 and NR1I3 rs2307424 on efavirenz pharmacokinetics. The analysis also indicates that some previous associations were not significant when interrogated across studies.
URI: http://hdl.handle.net/10662/20145
ISSN: 0305-7453
1460-2091
DOI: 10.1093/jac/dkz329
Colección:DTMQU - Artículos

Archivos
Archivo Descripción TamañoFormato 
jac_dkz329.pdf
???org.dspace.app.webui.jsptag.ItemTag.accessRestricted???
895,18 kBAdobe PDFDescargar    Pide una copia


Este elemento está sujeto a una licencia Licencia Creative Commons Creative Commons